Therapeutic use of a recombinant erythropoietin for prevention or treatment of chronic heart failure and associated fatigue or pain

Details for Australian Patent Application No. 2006203640 (hide)

Owner Baxter Healthcare S.A.

Inventors Thompson, Lawrence H.

Agent Peter Maxwell & Associates

Pub. Number AU-B-2006203640

Parent 2001291755

Filing date 17 August 2006

Wipo publication date 14 September 2006

Acceptance publication date 8 January 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 September 2006 Complete Application Filed

14 September 2006 Application Open to Public Inspection

  Published as AU-B-2006203640

8 January 2009 Application Accepted

  Published as AU-B-2006203640

7 May 2009 Standard Patent Sealed

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203641-Precision inflation control device

2006203639-Decoding of information in audio signals